MICHELLE PHELPS: Open Payments
NPI 1790243988 · ROSEBURG, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 9 payments from 6 companies in 2025. Trend: 2023 $204 · 2024 $206 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| ABBVIE INC. | 2 | $36 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $20 |
| Abbott Laboratories | 1 | $15 |
Products named: TRELEGY ELLIPTA, LEQVIO, VRAYLAR, ZENPEP, REZDIFFRA, FREESTYLE LIBRE 3.
Industry payments across OR — which companies pay providers there.
